PMS16 Longitudinal Analyses of Health-Related Quality of Life and Daily Activities Function Among HIP Fracture Population: A Real-World Prospective Cohort Study

Abstract

responder7216.16 and the total cost of 2 nd non responder was 8762.63 : IA HA is a cost effective option either vs NSAIDs or vs IA-CCs (ICER are 32081.17113 and 19617.53) respectively Conclusions: IA-HA in treatment of mild to moderate OA patients is cost -effective option based on who (3GDP/ Capita) .